Compare LUV & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | ILMN |
|---|---|---|
| Founded | 1967 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 20.4B |
| IPO Year | 1995 | 2000 |
| Metric | LUV | ILMN |
|---|---|---|
| Price | $52.09 | $117.67 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 18 | 17 |
| Target Price | $46.19 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 10.5M | 2.2M |
| Earning Date | 04-27-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | 3.95 | ★ 170.87 |
| EPS | 0.79 | ★ 5.45 |
| Revenue | N/A | ★ $4,343,000,000.00 |
| Revenue This Year | $14.13 | $6.56 |
| Revenue Next Year | $5.00 | $5.49 |
| P/E Ratio | $65.94 | ★ $21.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.82 | $68.70 |
| 52 Week High | $55.11 | $155.53 |
| Indicator | LUV | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 33.67 |
| Support Level | $49.80 | $114.03 |
| Resistance Level | $55.11 | $120.74 |
| Average True Range (ATR) | 1.88 | 4.56 |
| MACD | -0.17 | -1.34 |
| Stochastic Oscillator | 49.64 | 15.47 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In early 2026, Southwest will modify its cabins to offer some rows with extra legroom and will update its ticketing process and merchandising to offer assigned seats and more fare categories, including a basic economy class that will more directly compete with other airlines' offerings and appear for the first time in travel aggregators' search results.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.